| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, IgE | 113 | 2021 | 375 | 7.220 |
Why?
|
| Immunoglobulin E | 66 | 2021 | 1506 | 2.480 |
Why?
|
| Calcium Channels | 14 | 2024 | 623 | 2.190 |
Why?
|
| Receptors, Fc | 42 | 2000 | 537 | 2.120 |
Why?
|
| Mast Cells | 39 | 2021 | 1406 | 1.900 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 25 | 1992 | 318 | 1.600 |
Why?
|
| Calcium Signaling | 11 | 2024 | 737 | 1.370 |
Why?
|
| Hypersensitivity | 15 | 2021 | 1172 | 1.230 |
Why?
|
| Calcium | 29 | 2024 | 5792 | 1.080 |
Why?
|
| Receptors, IgG | 21 | 2005 | 564 | 1.000 |
Why?
|
| Protein-Tyrosine Kinases | 28 | 2004 | 2433 | 0.970 |
Why?
|
| Cell Degranulation | 9 | 2013 | 277 | 0.920 |
Why?
|
| Enzyme Precursors | 13 | 2004 | 166 | 0.790 |
Why?
|
| Signal Transduction | 42 | 2014 | 23645 | 0.710 |
Why?
|
| Calcium Channels, T-Type | 2 | 2019 | 28 | 0.690 |
Why?
|
| src-Family Kinases | 13 | 2004 | 539 | 0.590 |
Why?
|
| Basophils | 21 | 2014 | 407 | 0.540 |
Why?
|
| Cell Membrane | 14 | 2019 | 3655 | 0.520 |
Why?
|
| TRPC Cation Channels | 6 | 2024 | 111 | 0.500 |
Why?
|
| Phosphatidylinositol Phosphates | 4 | 2001 | 201 | 0.500 |
Why?
|
| Antigens, Differentiation | 11 | 1996 | 921 | 0.490 |
Why?
|
| Anaphylaxis | 7 | 2013 | 758 | 0.480 |
Why?
|
| NFATC Transcription Factors | 1 | 2016 | 393 | 0.450 |
Why?
|
| Endoplasmic Reticulum | 5 | 2019 | 1133 | 0.440 |
Why?
|
| Hypersensitivity, Immediate | 7 | 2004 | 349 | 0.440 |
Why?
|
| Calcium Channels, L-Type | 4 | 2019 | 244 | 0.430 |
Why?
|
| Cell Line | 51 | 2017 | 15597 | 0.410 |
Why?
|
| Phosphoric Monoester Hydrolases | 7 | 2001 | 414 | 0.410 |
Why?
|
| TRPM Cation Channels | 8 | 2012 | 141 | 0.410 |
Why?
|
| Trichuris | 1 | 2012 | 32 | 0.400 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 892 | 0.400 |
Why?
|
| Nut Hypersensitivity | 1 | 2012 | 33 | 0.400 |
Why?
|
| Membrane Proteins | 13 | 2009 | 7876 | 0.400 |
Why?
|
| Protein Tyrosine Phosphatases | 8 | 2013 | 458 | 0.400 |
Why?
|
| Transfection | 21 | 2008 | 5755 | 0.380 |
Why?
|
| Phosphorylation | 31 | 2008 | 8317 | 0.380 |
Why?
|
| Ovum | 1 | 2012 | 187 | 0.380 |
Why?
|
| Animals | 129 | 2024 | 169246 | 0.370 |
Why?
|
| Th1 Cells | 1 | 2016 | 1042 | 0.360 |
Why?
|
| T-Lymphocytes | 9 | 2019 | 10266 | 0.360 |
Why?
|
| Cation Transport Proteins | 2 | 2004 | 326 | 0.360 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 822 | 0.350 |
Why?
|
| Molecular Sequence Data | 36 | 2006 | 17622 | 0.350 |
Why?
|
| Th17 Cells | 1 | 2016 | 791 | 0.330 |
Why?
|
| Urticaria | 4 | 1999 | 151 | 0.330 |
Why?
|
| Phosphoproteins | 9 | 2005 | 2451 | 0.330 |
Why?
|
| Antigens, CD | 8 | 2005 | 4035 | 0.320 |
Why?
|
| Immunoglobulin G | 15 | 2005 | 4568 | 0.320 |
Why?
|
| Receptors, Antigen, B-Cell | 8 | 2003 | 547 | 0.320 |
Why?
|
| Macromolecular Substances | 22 | 2003 | 1435 | 0.310 |
Why?
|
| Mice | 70 | 2024 | 82029 | 0.310 |
Why?
|
| Models, Immunological | 3 | 2007 | 518 | 0.300 |
Why?
|
| Amino Acid Sequence | 27 | 2006 | 13421 | 0.280 |
Why?
|
| Receptors, Immunologic | 14 | 1999 | 1418 | 0.280 |
Why?
|
| Rats | 41 | 2013 | 23760 | 0.280 |
Why?
|
| Neoplasm Proteins | 3 | 2009 | 3603 | 0.280 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2016 | 2568 | 0.270 |
Why?
|
| Intracellular Space | 1 | 2008 | 199 | 0.270 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2008 | 1966 | 0.270 |
Why?
|
| Phosphotyrosine | 6 | 2008 | 458 | 0.260 |
Why?
|
| Enzyme Activation | 16 | 2003 | 3590 | 0.260 |
Why?
|
| Tyrosine | 11 | 2005 | 1427 | 0.250 |
Why?
|
| Passive Cutaneous Anaphylaxis | 4 | 2005 | 31 | 0.250 |
Why?
|
| Cloning, Molecular | 18 | 2006 | 4168 | 0.250 |
Why?
|
| Immunosorbent Techniques | 7 | 1990 | 174 | 0.240 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1996 | 492 | 0.230 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2005 | 283 | 0.230 |
Why?
|
| Type C Phospholipases | 5 | 1999 | 287 | 0.220 |
Why?
|
| 3T3 Cells | 8 | 2001 | 1084 | 0.220 |
Why?
|
| Lymphocyte Activation | 4 | 2016 | 5505 | 0.220 |
Why?
|
| Receptor Aggregation | 5 | 1995 | 72 | 0.220 |
Why?
|
| Lymphocytes | 2 | 2009 | 2614 | 0.220 |
Why?
|
| Polymorphism, Genetic | 7 | 2008 | 4249 | 0.210 |
Why?
|
| Immunoblotting | 7 | 2013 | 1647 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2005 | 2909 | 0.200 |
Why?
|
| Staphylococcal Protein A | 4 | 1986 | 39 | 0.200 |
Why?
|
| U937 Cells | 5 | 2004 | 260 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 15 | 2004 | 2892 | 0.190 |
Why?
|
| Cations | 1 | 2002 | 240 | 0.190 |
Why?
|
| Mice, Knockout | 13 | 2024 | 14488 | 0.190 |
Why?
|
| Autoantibodies | 6 | 2001 | 2121 | 0.180 |
Why?
|
| Jurkat Cells | 4 | 2006 | 740 | 0.180 |
Why?
|
| Ion Transport | 4 | 2006 | 322 | 0.180 |
Why?
|
| Up-Regulation | 5 | 2006 | 4146 | 0.180 |
Why?
|
| Isoenzymes | 5 | 2000 | 1688 | 0.180 |
Why?
|
| Base Sequence | 18 | 2002 | 12421 | 0.170 |
Why?
|
| Drosophila Proteins | 2 | 2007 | 1712 | 0.170 |
Why?
|
| B-Lymphocytes | 6 | 2001 | 4793 | 0.160 |
Why?
|
| Receptors, Purinergic P2X2 | 1 | 2019 | 8 | 0.160 |
Why?
|
| Macrophages | 4 | 2012 | 5799 | 0.160 |
Why?
|
| Gene Amplification | 2 | 2001 | 1095 | 0.160 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2019 | 72 | 0.160 |
Why?
|
| Leukemia, Basophilic, Acute | 6 | 2003 | 15 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2008 | 3740 | 0.160 |
Why?
|
| Genes | 7 | 1992 | 1824 | 0.160 |
Why?
|
| Intracellular Fluid | 3 | 2006 | 201 | 0.160 |
Why?
|
| Membrane Potentials | 5 | 2006 | 1090 | 0.150 |
Why?
|
| Models, Molecular | 12 | 2006 | 5403 | 0.150 |
Why?
|
| Recombinant Proteins | 14 | 2006 | 6514 | 0.150 |
Why?
|
| Glycoproteins | 2 | 2005 | 2202 | 0.150 |
Why?
|
| Receptors, Muscarinic | 2 | 1996 | 157 | 0.150 |
Why?
|
| Blood Proteins | 2 | 2001 | 1191 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2002 | 4528 | 0.150 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2019 | 130 | 0.150 |
Why?
|
| Allergens | 5 | 2021 | 1443 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 10 | 2003 | 6124 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2442 | 0.140 |
Why?
|
| Structure-Activity Relationship | 6 | 2008 | 3055 | 0.140 |
Why?
|
| Cytokines | 8 | 2016 | 7453 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 7 | 2008 | 3772 | 0.140 |
Why?
|
| Humans | 116 | 2021 | 768166 | 0.140 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 1726 | 0.140 |
Why?
|
| Autoimmune Diseases | 3 | 2001 | 2257 | 0.140 |
Why?
|
| Amino Acid Motifs | 4 | 2004 | 930 | 0.140 |
Why?
|
| Vaccines | 1 | 2005 | 842 | 0.140 |
Why?
|
| Patch-Clamp Techniques | 4 | 2008 | 927 | 0.130 |
Why?
|
| Protein Conformation | 11 | 2003 | 3956 | 0.130 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2001 | 246 | 0.130 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 3 | 2017 | 110 | 0.130 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2001 | 667 | 0.130 |
Why?
|
| Cell Cycle Proteins | 2 | 2000 | 3445 | 0.130 |
Why?
|
| Molecular Weight | 8 | 2002 | 2173 | 0.130 |
Why?
|
| GTP-Binding Proteins | 3 | 1996 | 948 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2006 | 2937 | 0.130 |
Why?
|
| Restriction Mapping | 6 | 2001 | 849 | 0.120 |
Why?
|
| Kinetics | 11 | 2001 | 6329 | 0.120 |
Why?
|
| Antigen Presentation | 4 | 2009 | 1251 | 0.120 |
Why?
|
| Serotonin | 5 | 2005 | 1043 | 0.120 |
Why?
|
| Immunoglobulin Fc Fragments | 3 | 2001 | 287 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2003 | 434 | 0.120 |
Why?
|
| Gene Expression Regulation | 10 | 2014 | 11928 | 0.120 |
Why?
|
| Dendritic Cells | 5 | 2014 | 2747 | 0.120 |
Why?
|
| Receptors, Antigen | 1 | 1994 | 51 | 0.120 |
Why?
|
| Phospholipases A | 1 | 1995 | 204 | 0.120 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 432 | 0.120 |
Why?
|
| Protein Folding | 2 | 1996 | 871 | 0.120 |
Why?
|
| Egg Hypersensitivity | 1 | 2014 | 47 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 11 | 1998 | 6231 | 0.110 |
Why?
|
| Cells, Cultured | 13 | 2014 | 19015 | 0.110 |
Why?
|
| Adoptive Transfer | 2 | 2013 | 825 | 0.110 |
Why?
|
| Lysophospholipids | 1 | 1996 | 338 | 0.110 |
Why?
|
| Antigens | 5 | 1999 | 1442 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 1995 | 262 | 0.110 |
Why?
|
| src Homology Domains | 4 | 1999 | 361 | 0.110 |
Why?
|
| Receptors, KIR | 1 | 2013 | 114 | 0.110 |
Why?
|
| Gene Expression | 6 | 2008 | 7598 | 0.110 |
Why?
|
| Phosphates | 2 | 1996 | 765 | 0.100 |
Why?
|
| Leukemia, Experimental | 9 | 1991 | 225 | 0.100 |
Why?
|
| Carya | 1 | 2012 | 2 | 0.100 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 424 | 0.100 |
Why?
|
| Antigen-Antibody Complex | 5 | 2001 | 513 | 0.100 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 702 | 0.100 |
Why?
|
| Trichuriasis | 1 | 2012 | 24 | 0.100 |
Why?
|
| Multigene Family | 2 | 2000 | 1081 | 0.100 |
Why?
|
| Monocytes | 5 | 2014 | 2605 | 0.100 |
Why?
|
| Cricetinae | 7 | 1999 | 2423 | 0.100 |
Why?
|
| Flow Cytometry | 12 | 2008 | 5902 | 0.100 |
Why?
|
| Langerhans Cells | 4 | 1994 | 169 | 0.100 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 3 | 2017 | 123 | 0.100 |
Why?
|
| DNA | 9 | 1996 | 7214 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 1996 | 812 | 0.100 |
Why?
|
| Transcription, Genetic | 8 | 2001 | 7608 | 0.100 |
Why?
|
| Conserved Sequence | 1 | 1995 | 1162 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 687 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 4 | 2000 | 121 | 0.090 |
Why?
|
| Interleukin-2 | 3 | 2006 | 1895 | 0.090 |
Why?
|
| Killer Cells, Natural | 6 | 1997 | 2211 | 0.090 |
Why?
|
| Autoimmunity | 2 | 2016 | 1361 | 0.090 |
Why?
|
| Ubiquitins | 1 | 1993 | 366 | 0.090 |
Why?
|
| Cell Communication | 2 | 2000 | 1660 | 0.090 |
Why?
|
| Phospholipase C gamma | 4 | 1999 | 131 | 0.090 |
Why?
|
| Chromosome Mapping | 3 | 1990 | 4620 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 781 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 2271 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 4 | 2000 | 224 | 0.090 |
Why?
|
| Malaria, Cerebral | 1 | 2011 | 136 | 0.090 |
Why?
|
| Immunoprecipitation | 3 | 2013 | 874 | 0.090 |
Why?
|
| Eosinophils | 5 | 2011 | 952 | 0.080 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1993 | 792 | 0.080 |
Why?
|
| Swine | 4 | 2012 | 5995 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1993 | 1057 | 0.080 |
Why?
|
| Chimera | 2 | 1996 | 454 | 0.080 |
Why?
|
| Histamine Release | 3 | 1999 | 134 | 0.080 |
Why?
|
| Neutrophils | 3 | 2012 | 3786 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 10 | 2016 | 22379 | 0.080 |
Why?
|
| Protein Binding | 11 | 2014 | 9343 | 0.080 |
Why?
|
| Sodium | 3 | 2004 | 1597 | 0.080 |
Why?
|
| Mastocytoma | 1 | 2008 | 5 | 0.080 |
Why?
|
| Bone Marrow Cells | 6 | 2012 | 2414 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2000 | 640 | 0.080 |
Why?
|
| Thymus Gland | 2 | 2009 | 1266 | 0.080 |
Why?
|
| Antibodies | 3 | 1997 | 2421 | 0.080 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 2003 | 355 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1996 | 1730 | 0.080 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 1995 | 283 | 0.080 |
Why?
|
| Vaccinia virus | 4 | 2003 | 328 | 0.080 |
Why?
|
| Disulfides | 1 | 1990 | 466 | 0.080 |
Why?
|
| Haptens | 3 | 1997 | 163 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 1767 | 0.080 |
Why?
|
| Blotting, Western | 6 | 2013 | 5027 | 0.080 |
Why?
|
| Interleukin-13 | 2 | 2001 | 390 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2003 | 2885 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2010 | 943 | 0.070 |
Why?
|
| Protein Kinase C | 2 | 2005 | 1207 | 0.070 |
Why?
|
| Dog Diseases | 1 | 2008 | 143 | 0.070 |
Why?
|
| CHO Cells | 5 | 1999 | 1379 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2000 | 91 | 0.070 |
Why?
|
| Cell Line, Transformed | 3 | 1998 | 866 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1972 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 1996 | 2819 | 0.070 |
Why?
|
| Inflammation | 1 | 2007 | 10873 | 0.070 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2009 | 320 | 0.070 |
Why?
|
| Cytotoxicity, Immunologic | 5 | 1997 | 1353 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 3814 | 0.070 |
Why?
|
| RNA Interference | 2 | 2006 | 2832 | 0.070 |
Why?
|
| Phosphopeptides | 3 | 1997 | 240 | 0.070 |
Why?
|
| Lipid Bilayers | 1 | 1989 | 379 | 0.070 |
Why?
|
| Cats | 2 | 2005 | 978 | 0.070 |
Why?
|
| Genetic Linkage | 2 | 1989 | 2342 | 0.070 |
Why?
|
| Extracellular Space | 1 | 2008 | 563 | 0.070 |
Why?
|
| Ion Channels | 2 | 2001 | 1043 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 669 | 0.070 |
Why?
|
| Mastocytosis | 1 | 2008 | 150 | 0.060 |
Why?
|
| Plasmapheresis | 3 | 1986 | 206 | 0.060 |
Why?
|
| Thiadiazoles | 1 | 2006 | 63 | 0.060 |
Why?
|
| Mitochondria | 1 | 2019 | 3681 | 0.060 |
Why?
|
| Hypotension | 2 | 1982 | 888 | 0.060 |
Why?
|
| Vitronectin | 1 | 2005 | 40 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1990 | 1305 | 0.060 |
Why?
|
| Mice, Transgenic | 7 | 2014 | 9561 | 0.060 |
Why?
|
| Phytohemagglutinins | 1 | 2004 | 165 | 0.060 |
Why?
|
| Alternative Splicing | 2 | 2016 | 1105 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2006 | 385 | 0.060 |
Why?
|
| Protein Kinase C-delta | 1 | 2005 | 115 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2008 | 725 | 0.060 |
Why?
|
| Proteins | 2 | 1996 | 6009 | 0.060 |
Why?
|
| Clone Cells | 1 | 2008 | 1670 | 0.060 |
Why?
|
| Cytosol | 3 | 2003 | 887 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 9 | 2005 | 9263 | 0.060 |
Why?
|
| Inositol Phosphates | 3 | 1999 | 175 | 0.060 |
Why?
|
| Phosphatidylinositols | 3 | 1994 | 280 | 0.060 |
Why?
|
| Exons | 3 | 2016 | 2394 | 0.050 |
Why?
|
| Cycloheximide | 2 | 2001 | 341 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2010 | 1135 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2011 | 1715 | 0.050 |
Why?
|
| Phospholipids | 3 | 1986 | 787 | 0.050 |
Why?
|
| Immunoglobulin M | 2 | 2000 | 1528 | 0.050 |
Why?
|
| Hemoperfusion | 1 | 1983 | 13 | 0.050 |
Why?
|
| Social Behavior | 1 | 2010 | 1147 | 0.050 |
Why?
|
| Tunicamycin | 2 | 1995 | 109 | 0.050 |
Why?
|
| Adenocarcinoma | 3 | 1986 | 6395 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4415 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 2003 | 157 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2007 | 1968 | 0.050 |
Why?
|
| Anilides | 1 | 2006 | 413 | 0.050 |
Why?
|
| Membrane Microdomains | 2 | 2003 | 205 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 114 | 0.050 |
Why?
|
| Immune Complex Diseases | 1 | 1982 | 50 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 5797 | 0.050 |
Why?
|
| Antibody Affinity | 2 | 1996 | 252 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 8054 | 0.050 |
Why?
|
| Models, Biological | 6 | 2003 | 9495 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2003 | 373 | 0.050 |
Why?
|
| Capsaicin | 1 | 2003 | 235 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 1 | 2003 | 426 | 0.050 |
Why?
|
| Renal Dialysis | 2 | 1982 | 1791 | 0.050 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2001 | 70 | 0.050 |
Why?
|
| Anti-Allergic Agents | 1 | 2003 | 156 | 0.050 |
Why?
|
| Enzyme Inhibitors | 4 | 2008 | 3728 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 188 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2005 | 891 | 0.050 |
Why?
|
| RNA, Messenger | 8 | 2005 | 12800 | 0.050 |
Why?
|
| Solubility | 4 | 1998 | 1083 | 0.050 |
Why?
|
| Leucine | 3 | 2000 | 547 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 4580 | 0.050 |
Why?
|
| Fibronectins | 1 | 2005 | 722 | 0.050 |
Why?
|
| Cell Movement | 2 | 2014 | 5210 | 0.050 |
Why?
|
| Fear | 1 | 2010 | 1495 | 0.050 |
Why?
|
| Peptide Mapping | 3 | 1997 | 260 | 0.050 |
Why?
|
| Protein Kinases | 2 | 2001 | 1611 | 0.050 |
Why?
|
| Isoleucine | 1 | 2000 | 111 | 0.040 |
Why?
|
| Asthma | 2 | 2014 | 6291 | 0.040 |
Why?
|
| Sphingosine | 2 | 2008 | 308 | 0.040 |
Why?
|
| Drug Design | 2 | 2003 | 1046 | 0.040 |
Why?
|
| Immunoglobulin Fragments | 1 | 2000 | 84 | 0.040 |
Why?
|
| Learning | 1 | 2010 | 1759 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2007 | 880 | 0.040 |
Why?
|
| Mutation | 9 | 2008 | 30238 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 1110 | 0.040 |
Why?
|
| Carbachol | 2 | 2003 | 223 | 0.040 |
Why?
|
| Sequence Alignment | 4 | 2006 | 2179 | 0.040 |
Why?
|
| Exocytosis | 2 | 2006 | 323 | 0.040 |
Why?
|
| Detergents | 5 | 1986 | 235 | 0.040 |
Why?
|
| Hematopoiesis | 2 | 2001 | 2059 | 0.040 |
Why?
|
| Mice, Inbred NZB | 2 | 1989 | 57 | 0.040 |
Why?
|
| Mice, Inbred AKR | 2 | 1989 | 104 | 0.040 |
Why?
|
| Schistosomiasis mansoni | 2 | 1997 | 94 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2001 | 426 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 1994 | 1751 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2006 | 1191 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2001 | 429 | 0.040 |
Why?
|
| Biopolymers | 1 | 2000 | 183 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 2 | 1989 | 286 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2006 | 899 | 0.040 |
Why?
|
| Valine | 1 | 2000 | 410 | 0.040 |
Why?
|
| Cell Differentiation | 6 | 2008 | 11669 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 2000 | 252 | 0.040 |
Why?
|
| Tetanus Toxoid | 1 | 1999 | 188 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 18349 | 0.040 |
Why?
|
| Interleukin-4 | 2 | 1999 | 1156 | 0.040 |
Why?
|
| Blood Platelets | 2 | 2001 | 2479 | 0.040 |
Why?
|
| Sepsis | 1 | 2012 | 2608 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3096 | 0.040 |
Why?
|
| Mice, Inbred DBA | 2 | 1989 | 624 | 0.040 |
Why?
|
| Potassium | 1 | 2002 | 1315 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 3711 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2001 | 2748 | 0.040 |
Why?
|
| Dogs | 3 | 2008 | 3845 | 0.040 |
Why?
|
| Dinitrobenzenes | 1 | 1997 | 37 | 0.040 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 1997 | 43 | 0.040 |
Why?
|
| Phospholipase C beta | 1 | 2017 | 49 | 0.040 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 1996 | 43 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2001 | 931 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2001 | 1134 | 0.030 |
Why?
|
| Glycine | 1 | 2000 | 672 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 1997 | 1754 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2000 | 992 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 3428 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1996 | 199 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2013 | 12168 | 0.030 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1996 | 101 | 0.030 |
Why?
|
| Ovalbumin | 2 | 2014 | 677 | 0.030 |
Why?
|
| Parasites | 1 | 1999 | 160 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 525 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 1996 | 337 | 0.030 |
Why?
|
| Genistein | 1 | 1996 | 87 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2003 | 859 | 0.030 |
Why?
|
| Glycosylation | 2 | 1998 | 1100 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2000 | 717 | 0.030 |
Why?
|
| HLA-C Antigens | 1 | 1996 | 146 | 0.030 |
Why?
|
| Extracorporeal Circulation | 2 | 1986 | 181 | 0.030 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 1996 | 199 | 0.030 |
Why?
|
| Cross-Linking Reagents | 2 | 2014 | 693 | 0.030 |
Why?
|
| Isoflavones | 1 | 1996 | 139 | 0.030 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1995 | 93 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2008 | 10474 | 0.030 |
Why?
|
| Interleukin-3 | 2 | 1997 | 425 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 1683 | 0.030 |
Why?
|
| Trachea | 1 | 2001 | 1095 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 1995 | 197 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2001 | 1530 | 0.030 |
Why?
|
| Cell Migration Assays | 1 | 2014 | 22 | 0.030 |
Why?
|
| Micelles | 2 | 1985 | 191 | 0.030 |
Why?
|
| Pain | 1 | 2010 | 5100 | 0.030 |
Why?
|
| Papain | 1 | 2014 | 66 | 0.030 |
Why?
|
| Binding Sites | 4 | 2001 | 6020 | 0.030 |
Why?
|
| Hemodynamics | 2 | 1982 | 4194 | 0.030 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1996 | 249 | 0.030 |
Why?
|
| Thapsigargin | 2 | 2008 | 102 | 0.030 |
Why?
|
| Skin | 4 | 1997 | 4503 | 0.030 |
Why?
|
| Dermatitis, Atopic | 3 | 1997 | 737 | 0.030 |
Why?
|
| Peptides | 2 | 1997 | 4354 | 0.030 |
Why?
|
| Adenosine Triphosphate | 2 | 2001 | 2004 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 203 | 0.030 |
Why?
|
| Chronic Disease | 3 | 1998 | 9384 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 2013 | 1550 | 0.030 |
Why?
|
| Phycoerythrin | 1 | 1993 | 9 | 0.030 |
Why?
|
| Body Temperature | 1 | 1997 | 780 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 1995 | 429 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1997 | 1888 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 1996 | 563 | 0.030 |
Why?
|
| Chemical Precipitation | 2 | 1991 | 175 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 17140 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 1986 | 21206 | 0.030 |
Why?
|
| Binding, Competitive | 4 | 1996 | 1142 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 1992 | 113 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 1997 | 571 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1992 | 100 | 0.030 |
Why?
|
| Histamine | 2 | 1992 | 496 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2001 | 648 | 0.030 |
Why?
|
| Schistosoma mansoni | 1 | 1994 | 156 | 0.030 |
Why?
|
| DNA Probes | 2 | 1990 | 542 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 190 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 1999 | 1494 | 0.030 |
Why?
|
| Arsenicals | 1 | 1992 | 117 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1994 | 574 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2001 | 2457 | 0.020 |
Why?
|
| Methionine | 2 | 1992 | 573 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 482 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 2 | 1996 | 3409 | 0.020 |
Why?
|
| Th2 Cells | 1 | 1997 | 1078 | 0.020 |
Why?
|
| Thermodynamics | 2 | 2001 | 591 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1992 | 775 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1994 | 354 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 369 | 0.020 |
Why?
|
| Ligands | 3 | 2008 | 3284 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 705 | 0.020 |
Why?
|
| Insulin | 1 | 2006 | 6607 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1996 | 1505 | 0.020 |
Why?
|
| Ultrafiltration | 2 | 1982 | 48 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2003 | 3402 | 0.020 |
Why?
|
| Crystallography, X-Ray | 3 | 2001 | 1951 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2016 | 905 | 0.020 |
Why?
|
| Endosomes | 1 | 2014 | 522 | 0.020 |
Why?
|
| Perfusion | 2 | 1986 | 1401 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 1993 | 661 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 4786 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2014 | 498 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1983 | 2541 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 1998 | 446 | 0.020 |
Why?
|
| Plasmodium berghei | 1 | 2011 | 161 | 0.020 |
Why?
|
| Biological Transport | 1 | 1995 | 2085 | 0.020 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2010 | 40 | 0.020 |
Why?
|
| Female | 13 | 2016 | 397192 | 0.020 |
Why?
|
| Primates | 1 | 1993 | 520 | 0.020 |
Why?
|
| Peritonitis | 1 | 2012 | 368 | 0.020 |
Why?
|
| Genomic Library | 1 | 1990 | 189 | 0.020 |
Why?
|
| Feedback | 1 | 1994 | 799 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2002 | 3703 | 0.020 |
Why?
|
| Kidney | 2 | 2002 | 7064 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1982 | 2496 | 0.020 |
Why?
|
| Endocytosis | 1 | 2014 | 956 | 0.020 |
Why?
|
| Species Specificity | 2 | 1996 | 2415 | 0.020 |
Why?
|
| Hybridomas | 1 | 1990 | 444 | 0.020 |
Why?
|
| Sodium Chloride | 2 | 1982 | 584 | 0.020 |
Why?
|
| Immunologic Capping | 1 | 1989 | 30 | 0.020 |
Why?
|
| Immunoglobulin epsilon-Chains | 1 | 1989 | 16 | 0.020 |
Why?
|
| DNA Primers | 1 | 1993 | 2828 | 0.020 |
Why?
|
| Crystallization | 2 | 2001 | 520 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2008 | 63 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 1989 | 297 | 0.020 |
Why?
|
| Spectrin | 1 | 1988 | 176 | 0.020 |
Why?
|
| Lysosomes | 1 | 2014 | 938 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 897 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 1951 | 0.020 |
Why?
|
| Static Electricity | 1 | 2008 | 260 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 1998 | 3228 | 0.020 |
Why?
|
| Cell Survival | 2 | 2012 | 5777 | 0.020 |
Why?
|
| Gene Targeting | 2 | 2001 | 841 | 0.020 |
Why?
|
| Cysteine | 1 | 1992 | 897 | 0.020 |
Why?
|
| Granulocytes | 1 | 1989 | 551 | 0.020 |
Why?
|
| Biological Factors | 1 | 1989 | 156 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1998 | 4176 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 1988 | 752 | 0.020 |
Why?
|
| Gene Library | 1 | 1990 | 1064 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2010 | 368 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1996 | 1901 | 0.020 |
Why?
|
| Liver | 2 | 1997 | 7577 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1993 | 6082 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 2219 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1993 | 3074 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4937 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4283 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 488 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 414 | 0.020 |
Why?
|
| Gene Frequency | 1 | 1993 | 3623 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 1 | 1986 | 311 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13676 | 0.020 |
Why?
|
| Polyethylene Glycols | 3 | 1986 | 1196 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1986 | 863 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2000 | 6611 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1989 | 1617 | 0.020 |
Why?
|
| Iodine Radioisotopes | 2 | 1985 | 1034 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1989 | 1525 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1991 | 1076 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1983 | 5446 | 0.010 |
Why?
|
| Recurrence | 1 | 1997 | 8509 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2005 | 816 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1993 | 2885 | 0.010 |
Why?
|
| Peritoneal Cavity | 2 | 1997 | 135 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1996 | 5151 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1984 | 189 | 0.010 |
Why?
|
| Glutamine | 1 | 2006 | 577 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1991 | 1542 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1989 | 1744 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1990 | 1801 | 0.010 |
Why?
|
| Male | 12 | 2010 | 364719 | 0.010 |
Why?
|
| Plasma Exchange | 1 | 1984 | 159 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2003 | 89 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 2 | 1994 | 316 | 0.010 |
Why?
|
| Benzamides | 1 | 2008 | 1379 | 0.010 |
Why?
|
| Escherichia coli | 2 | 2001 | 4214 | 0.010 |
Why?
|
| Binding Sites, Antibody | 2 | 1997 | 340 | 0.010 |
Why?
|
| Protein Biosynthesis | 2 | 2005 | 2094 | 0.010 |
Why?
|
| Alleles | 1 | 1993 | 6894 | 0.010 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2001 | 13 | 0.010 |
Why?
|
| Interleukin-13 Receptor alpha1 Subunit | 1 | 2001 | 23 | 0.010 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1982 | 115 | 0.010 |
Why?
|
| TRPV Cation Channels | 1 | 2003 | 244 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1981 | 82 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2001 | 398 | 0.010 |
Why?
|
| Uremia | 1 | 1982 | 202 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 1656 | 0.010 |
Why?
|
| Thiazoles | 1 | 2008 | 1542 | 0.010 |
Why?
|
| Pyrophosphatases | 1 | 2001 | 142 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 2001 | 262 | 0.010 |
Why?
|
| Immunophenotyping | 2 | 1996 | 1864 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2001 | 243 | 0.010 |
Why?
|
| Ascites | 1 | 1982 | 338 | 0.010 |
Why?
|
| Piperidines | 1 | 2008 | 1667 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2001 | 347 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2001 | 472 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2010 | 3583 | 0.010 |
Why?
|
| Rabbits | 1 | 1985 | 4772 | 0.010 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1999 | 74 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1994 | 2474 | 0.010 |
Why?
|
| Nociceptors | 1 | 2003 | 460 | 0.010 |
Why?
|
| Chickens | 1 | 2001 | 845 | 0.010 |
Why?
|
| Oncogene Protein v-akt | 1 | 1999 | 130 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1999 | 342 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 8128 | 0.010 |
Why?
|
| Time Factors | 4 | 1996 | 40218 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 1216 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2000 | 1065 | 0.010 |
Why?
|
| Blood | 1 | 1981 | 599 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1993 | 5804 | 0.010 |
Why?
|
| Strongyloides | 1 | 1997 | 3 | 0.010 |
Why?
|
| Nippostrongylus | 1 | 1997 | 21 | 0.010 |
Why?
|
| Mesothelioma | 1 | 1984 | 811 | 0.010 |
Why?
|
| Peritoneal Neoplasms | 1 | 1984 | 714 | 0.010 |
Why?
|
| Homeostasis | 1 | 2008 | 3348 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 1470 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2006 | 2592 | 0.010 |
Why?
|
| Strongylida Infections | 1 | 1997 | 48 | 0.010 |
Why?
|
| Leukocytes | 2 | 1997 | 2035 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1999 | 828 | 0.010 |
Why?
|
| Dinitrophenols | 1 | 1996 | 56 | 0.010 |
Why?
|
| Viral Matrix Proteins | 1 | 1998 | 193 | 0.010 |
Why?
|
| Tryptophan | 1 | 1998 | 482 | 0.010 |
Why?
|
| Pyridines | 1 | 2008 | 2894 | 0.010 |
Why?
|
| Agammaglobulinemia | 1 | 1998 | 174 | 0.010 |
Why?
|
| Dimerization | 1 | 1998 | 887 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 1996 | 120 | 0.010 |
Why?
|
| Interleukins | 1 | 2001 | 796 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1996 | 194 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 1996 | 147 | 0.010 |
Why?
|
| Octoxynol | 2 | 1986 | 76 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1982 | 8543 | 0.010 |
Why?
|
| Cattle | 1 | 2001 | 3819 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 1996 | 313 | 0.010 |
Why?
|
| Leukemia | 1 | 1983 | 1519 | 0.010 |
Why?
|
| Eosinophil Peroxidase | 1 | 1994 | 22 | 0.010 |
Why?
|
| Peptide Hydrolases | 2 | 1990 | 610 | 0.010 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 1995 | 104 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 1377 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1996 | 609 | 0.010 |
Why?
|
| Peroxidases | 1 | 1994 | 135 | 0.010 |
Why?
|
| Glucose | 1 | 2006 | 4352 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2008 | 12465 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1995 | 491 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1996 | 619 | 0.010 |
Why?
|
| Platelet Activation | 1 | 1997 | 644 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 1996 | 444 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1996 | 877 | 0.010 |
Why?
|
| RNA | 2 | 1996 | 2720 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5812 | 0.010 |
Why?
|
| Neurons | 1 | 2013 | 9514 | 0.010 |
Why?
|
| Galectin 3 | 1 | 1995 | 240 | 0.010 |
Why?
|
| Transgenes | 1 | 1996 | 1016 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1996 | 899 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 6229 | 0.010 |
Why?
|
| Immunization | 1 | 1997 | 1219 | 0.010 |
Why?
|
| Filtration | 2 | 1984 | 229 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1997 | 54926 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1497 | 0.010 |
Why?
|
| Phagocytes | 1 | 1994 | 294 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 1219 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1207 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1999 | 1361 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1992 | 221 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1982 | 1960 | 0.010 |
Why?
|
| Protein Multimerization | 1 | 1996 | 965 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 13671 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 1703 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1996 | 1676 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1996 | 1361 | 0.010 |
Why?
|
| Adult | 5 | 1997 | 223646 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1986 | 3626 | 0.010 |
Why?
|
| Microinjections | 1 | 1990 | 321 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1990 | 557 | 0.010 |
Why?
|
| Echocardiography | 1 | 1982 | 5047 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1996 | 1854 | 0.010 |
Why?
|
| Eosinophilia | 1 | 1994 | 556 | 0.010 |
Why?
|
| Autoradiography | 1 | 1990 | 727 | 0.000 |
Why?
|
| Leukemia, Mast-Cell | 1 | 1988 | 13 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1990 | 699 | 0.000 |
Why?
|
| Reference Values | 1 | 1995 | 4938 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1996 | 4120 | 0.000 |
Why?
|
| Karyotyping | 1 | 1990 | 1177 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1997 | 1516 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1997 | 2935 | 0.000 |
Why?
|
| Xenopus laevis | 1 | 1990 | 967 | 0.000 |
Why?
|
| Skin Diseases | 1 | 1994 | 1085 | 0.000 |
Why?
|
| Brain | 1 | 2013 | 27360 | 0.000 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 3610 | 0.000 |
Why?
|
| Mortality | 1 | 1997 | 2911 | 0.000 |
Why?
|
| Oocytes | 1 | 1990 | 1172 | 0.000 |
Why?
|
| Heart Rate | 1 | 1997 | 4214 | 0.000 |
Why?
|
| Plasmids | 1 | 1990 | 2269 | 0.000 |
Why?
|
| Middle Aged | 3 | 1986 | 223492 | 0.000 |
Why?
|
| Chemistry | 1 | 1984 | 327 | 0.000 |
Why?
|
| Blood Cell Count | 1 | 1986 | 406 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1984 | 486 | 0.000 |
Why?
|
| Cell Division | 1 | 1992 | 4473 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1992 | 1930 | 0.000 |
Why?
|
| Azides | 1 | 1983 | 120 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1984 | 525 | 0.000 |
Why?
|
| Glucosamine | 1 | 1983 | 128 | 0.000 |
Why?
|
| Methyltransferases | 1 | 1986 | 373 | 0.000 |
Why?
|
| Plasma Volume | 1 | 1982 | 32 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1986 | 855 | 0.000 |
Why?
|
| Plasma Substitutes | 1 | 1982 | 57 | 0.000 |
Why?
|
| Venous Pressure | 1 | 1982 | 55 | 0.000 |
Why?
|
| Membranes | 1 | 1982 | 164 | 0.000 |
Why?
|
| Renal Veins | 1 | 1982 | 103 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1984 | 2560 | 0.000 |
Why?
|
| Amino Acids | 1 | 1987 | 1716 | 0.000 |
Why?
|
| Liposomes | 1 | 1984 | 790 | 0.000 |
Why?
|
| Suction | 1 | 1982 | 268 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1999 | 26422 | 0.000 |
Why?
|
| Temperature | 1 | 1984 | 2234 | 0.000 |
Why?
|
| Lipid Metabolism | 1 | 1986 | 1904 | 0.000 |
Why?
|
| Aged | 2 | 1986 | 171504 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1986 | 4755 | 0.000 |
Why?
|